This product is an unconjugated anti-Human Complement C5 Monoclonal antibody (CTJS-536) generated from the Recombinant. The antibody can be used for ELISA.
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
| Clonality | Monoclonal |
| Clone | CTJS-536 |
| Host Animal | Recombinant |
| Isotype | IgG2/4, κ |
| Immunogen | Human Complement C5 |
| Species Reactivity | Human |
| Applications | ELISA |
| Application Notes | The optimal working dilutions should be determined by the end user. |
| Specificity | This antibody reacts with Human Complement C5. |
| Purity | ≥98% as determined by SDS-PAGE |
| Conjugation | Unconjugated |
| Format | Liquid |
| Size | 200 µg |
| Storage | Store at 4°C for short term. Store at -20°C for long term. Avoid freeze-thaw cycle. |
| Type | Primary Antibody |
| Target Name | C5 |
| Alternative Names | Complement C5; C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 4; Complement Component 5; C5a Anaphylatoxin; Prepro-C5; C5a; C5b; Anaphylatoxin C5a Analog; C5 |
| Gene ID | 727 |
| UniProt ID | P01031 |
| Introduction | Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled. Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. |